Arcturus Therapeutics Holdings Inc (ARCT) — Cash Flow Reinvestment Rate
Arcturus Therapeutics Holdings Inc (ARCT) has a Cash Flow Reinvestment Rate of 0.01x as of June 2023, reinvesting $708.00K (capex $354.00K plus investments $-354.00K) from operating cash flow of $50.81 Million. See ARCT free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Arcturus Therapeutics Holdings Inc Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for Arcturus Therapeutics Holdings Inc across 1 annual periods. For the full cash flow conversion analysis, see ARCT cash flow conversion.
Annual Cash Flow Reinvestment Rate for Arcturus Therapeutics Holdings Inc (2022–2022)
Year-by-year capital reinvestment analysis for Arcturus Therapeutics Holdings Inc. See ARCT FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.48x | $15.45 Million | $31.99 Million | $7.73 Million | — |